Chinese-made Vaccines Boost Global Response To COVID-19

Chinese-made vaccines boost global response to COVID-19

China has been contributing to the world's fight against COVID-19 as it is endeavoring to make its vaccines a global public good

BEIJING (APP - UrduPoint / Pakistan Point News - 21st Jan, 2021 ) :China has been contributing to the world's fight against COVID-19 as it is endeavoring to make its vaccines a global public good.

In Chile, the country's public health institute on Wednesday approved the emergency use of a vaccine against the novel coronavirus disease developed by Chinese firm Sinovac Biotech.

"We obtained very good results regarding the manufacturing quality ... We are approving a safe and effective vaccine for the population," said Heriberto Garcia, acting director of the institute.

The emergency approval of the Chinese-made vaccine will boost Chile's mass vaccination campaign, Health Minister Enrique Paris said Wednesday.

"This is very important news ... millions of doses of this vaccine will allow us to vaccinate many people to try to control the virus," Paris said.

On Tuesday, Serbian Health Minister Zlatibor Loncar received Sinopharm's COVID-19 vaccine, becoming the first person to receive the vaccine in the country.

After the vaccination, Loncar told the citizens to get vaccinated because that is "the only way" for Serbia to fight the novel coronavirus.

He pointed out that the Chinese vaccine is the third registered vaccine in Serbia, after the Pfizer-BioNtech and the Sputnik V vaccines, and these are efficient and safe vaccines.

One million doses of the Sinopharm's vaccine arrived in Serbia on Saturday and were welcomed at the Belgrade Airport by President Aleksandar Vucic.

Iraqi Ministry of Health on Tuesday said in a brief statement that the Iraqi National board for Selection of Drugs (NBSD) had approved the emergency use of China's Sinopharm and British AstraZeneca vaccines to contain the spread of the COVID-19 pandemic in the country.

Previously, the NBSD already approved the emergency use of the Pfizer-BioNTech vaccine to combat the pandemic.

At the same time, gaps in access to COVID-19 vaccines, especially those between the developed and developing countries, have alerted the international community.